Reutzel-Edens; Susan Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reutzel-Edens; Susan Marie.The latest application filed is for "4--5-(propan-2-yl)-1h-pyrazol-3-yl beta-d glucopyranoside acetate".

Company Profile

0.6.6

Reutzel-Edens; Susan Marie - Zionsville IN
Reutzel-Edens; Susan Marie - Indianapolis IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}- -5-(propan-2-yl)-1H-pyrazol-3-yl beta-D glucopyranoside acetate Grant 9,573,970 - Reutzel-Edens February 21, 2	2017-02-21
4--5-(propan-2-yl)-1h-pyrazol-3-yl Beta-d Glucopyranoside Acetate App 20160215011 - Reutzel-Edens; Susan Marie	2016-07-28
Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4- -yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride Grant 8,114,901 - Bush , et al. February 14, 2	2012-02-14
Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]- -2-hydroxypropoxy}quinoline Grant 7,582,762 - Bush , et al. September 1, 2	2009-09-01
Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone Grant 7,381,826 - Borghese , et al. June 3, 2	2008-06-03
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl) Piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole Mono-hydrochloride App 20070270465 - Bush; Julie Kay ; et al.	2007-11-22
Novel Salt And Crystalline Forms Of (2r)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]- -2-hydroxypropoxy}quinoline App 20070244124 - Bush; Julie Kay ; et al.	2007-10-18
Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]- -2-hydroxypropoxy}quinoline Grant 7,282,585 - Bush , et al. October 16, 2	2007-10-16
Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone App 20070078166 - Borghese; Alfio ; et al.	2007-04-05
Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]b- enzoyl]-L-glutamic acid and process therefor Grant 7,138,521 - Chelius , et al. November 21, 2	2006-11-21
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2ylmethyl)p- iperidin-4-yl]-1h- pyrrole mono-hydrochloride App 20050288332 - Bush, Julie Kay ; et al.	2005-12-29
Novel salt and crystalline forms of (2r)-anti-5-{3-[4-(10,11-difluorometha- nodibenzosuber- 5-yl)piperazin-1-yl]- 2-hydroxypropoxy}quinoline App 20040097519 - Bush, Julie Kay ; et al.	2004-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.